These results were in line with our findings that, in severe acute HF patients requiring hospitalization, higher plasma NT-proBNP levels at initiation presentation could only independently predict shorter-term (i.e., one month and three months), but not longer-term mortality (more than three months). This evidence concerns the gene NPPB and hydrops fetalis.